Saramago P
ORCID: 0000-0001-9063-8590
· 1 paper in corpus
BackgroundMulti-indication cancer drugs receive licensing extensions to include additional indications, as trial evidence on treatment effectiveness accumulates. We investigate how sharing information across indications can strengthen the i…